Cargando…
Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current eviden...
Autores principales: | Futatsugi, Hiroyuki, Iwabu, Masato, Okada-Iwabu, Miki, Okamoto, Koh, Amano, Yosuke, Morizaki, Yutaka, Kadowaki, Takashi, Yamauchi, Toshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655538/ https://www.ncbi.nlm.nih.gov/pubmed/33195481 http://dx.doi.org/10.3389/fcvm.2020.593061 |
Ejemplares similares
-
Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases
por: Iwabu, Masato, et al.
Publicado: (2019) -
Adiponectin/adiponectin receptor in disease and aging
por: Iwabu, Masato, et al.
Publicado: (2015) -
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
por: Okada-Iwabu, Miki, et al.
Publicado: (2015) -
A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis
por: Asahara, Naomi, et al.
Publicado: (2023) -
AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice
por: Iwabu, Masato, et al.
Publicado: (2021)